Cyclic di-nucleotide compounds as sting agonists

A class of polycyclic compounds of general formula (I), wherein Base1, Base2, Y, Za, Xa, Xa1, Xb, Xb1, Xc, Xc1, Xd, Xd1, R1, R1a, R2, R2a, R3, R4, R4a, R5, R6, R6a, R7, R7a, R8, R8a, and R9 are defined herein, that may be useful as inductors of type I interferon production, specifically as STING act...

Full description

Saved in:
Bibliographic Details
Main Authors Lu, Min, Trotter, Benjamin Wesley, Chang, Wonsuk, Cumming, Jared N, Bennett, Frank, Lim, Jongwon, Wu, Wen-Lian, Andresen, Brian M, Childers, Matthew Lloyd
Format Patent
LanguageEnglish
Published 27.06.2023
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:A class of polycyclic compounds of general formula (I), wherein Base1, Base2, Y, Za, Xa, Xa1, Xb, Xb1, Xc, Xc1, Xd, Xd1, R1, R1a, R2, R2a, R3, R4, R4a, R5, R6, R6a, R7, R7a, R8, R8a, and R9 are defined herein, that may be useful as inductors of type I interferon production, specifically as STING active agents, are provided. Also provided are processes for the synthesis and use of compounds.
Bibliography:Application Number: US201816771814